SCOPUS 정보 검색 플랫폼

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 49, Issue 7, 2002, Pages

Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy

(1) Moskowitz, Craig a

a MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

Author keywords

ICE chemotherapy; Ifosfamide; Refractory lymphoma; Risk adapted therapy

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DATA BASE; DOSE RESPONSE; DRUG SAFETY; HODGKIN DISEASE; HUMAN; NONHODGKIN LYMPHOMA; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION RESPONSE; STEM CELL TRANSPLANTATION; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; HUMANS; IFOSFAMIDE; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK; TREATMENT OUTCOME;

EID: 0036250081 PISSN: 09439404 EISSN: None Source Type: Journal
DOI: None Document Type: Conference Paper

Times cited : (18)

References (7)

1
- 0032761285
- Ifosfamide, carboplatin and etoposide, a highly effective cytoreduction and peripheral blood progenitor cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma
- (1999) J Clin Oncol , vol.12 , pp. 3776-3785
- Moskowitz, C.H.¹ Bertino, J.² Glassman, J.³

2
- 0008972026
- Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
- Orlando, 7-11 December 2001. Abstract 1459
- (2002) The American Society of Hematology 43rd Annual Meeting
- Kewalramani, T.¹ Zelenetz, A.² Bertino, J.³ Donnelly, G.⁴ Hedrick, E.⁵ Noy, A.⁶ O'Connor, O.⁷ Portlock, C.⁸ Straus, D.⁹ Yahalom, J.¹⁰ Gencarelli, A.¹¹ Remy, D.¹² Qin, J.¹³ Nimer, S.¹⁴ Moskowitz, C.¹⁵

3
- 0034307538
- High dose therapy and ASCT for patients with primary refractory aggressive NHL
- (2000) Blood , vol.96 , pp. 2399-2404
- Kewalramani, T.¹ Zelenetz, A.D.² Hedrick, E.E.³ Yahalom, J.⁴ Nimer, S.D.⁵ Moskowitz, C.H.⁶

4
- 0027251258
- Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease
- (1993) J Clin Oncol , vol.11 , pp. 1062-1070
- Yahalom, J.¹ Gulati, S.C.² Toia, M.³

5
- 0035253827
- A two step comprehensive chemoradiotherapy program for relapsed and refractory Hodgkin's disease: An intent to treat analysis and development of a prognostic model
- (2001) Blood , vol.97 , pp. 616-623
- Moskowitz, C.H.¹ Nimer, S.D.² Portlock, C.S.³ Straus, D.J.⁴ Hedrick, E.E.⁵ Gonzalez, M.⁶ Walits, J.⁷ Trippett, T.M.⁸ Zelenetz, A.D.⁹ Yahalom, J.¹⁰

6
- 0030942265
- Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
- (1997) Blood , vol.89 , pp. 814-822
- Yuen, A.R.¹ Rosenberg, S.A.² Hoppe, R.T.³

7
- 0032984816
- The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma
- (1999) Bone Marrow Transplant , vol.23 , pp. 561-567
- Moskowitz, C.H.¹ Nimer, S.D.² Glassman, J.R.³ Portlock, C.S.⁴ Yahalom, J.⁵ Straus, D.J.⁶ O'Brien, J.P.⁷ Elkin, N.⁸ Bertino, J.R.⁹ Zelenetz, A.D.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.